NEW YORK, Aug. 19, 2021 /PRNewswire/ -- The Europe urethral bulking systems market was valued US$ 21.2 Mn in 2020, and is expected to accelerate at a decent CAGR of approximately 6% over the forecast ...

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...

December 4, 2006 -- The US Food and Drug Administration (FDA) has approved a urethral bulking agent for the treatment of stress urinary incontinence in women; a propylene mesh urethral sling for the ...

Bulkamid® Urethral Bulking System is indicated for urethral injection for the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) in adult women who have SUI or ...

A study documents high state-by-state variation in the use of urethral bulking and sling placement to treat stress urinary incontinence. Although urinary incontinence is prevalent in the United States ...

Boston Scientific’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant ...